- Synthesis Development of the Selective Estrogen Receptor Degrader (SERD) LSZ102 from a Suzuki Coupling to a C-H Activation Strategy
-
The development of the synthetic process to the selective estrogen receptor degrader (SERD) drug candidate LSZ102 from the medicinal chemistry synthesis to the streamlined large-scale manufacturing route is described. The synthesis of LSZ102 could be sign
- Baenziger, Markus,Baierl, Marcel,Devanathan, Krishnaswamy,Eswaran, Sumesh,Fu, Peng,Gschwend, Bjoern,Haller, Michael,Kasinathan, Gopu,Kovacic, Nikola,Langlois, Audrey,Li, Yongfeng,Schuerch, Friedrich,Shen, Xiaodong,Wan, Yinbo,Wickendick, Regina,Xie, Siwei,Zhang, Kai
-
p. 1405 - 1419
(2020/10/12)
-
- AMINOISOXAZOLINE COMPOUNDS AS AGONISTS OF ALPHA7-NICOTINIC ACETYLCHOLINE RECEPTORS
-
The present invention relates to novel aminoisoxazoline compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.
- -
-
Paragraph 00450; 00451
(2017/05/19)
-